Nabilone
- Level
- Commodity
- Parent
- 51171800
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171844This classification denotes an antiemetic agent with the molecular formula C24H36O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2N4O9L084N, chemically known as 9h-dibenzo(b,d)pyran-9-one, 3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,6-dimethyl-, trans-(.+/-.)- but generally known as nabilone, which bears US NIH Compound Identifier 39860. European Medicines Agency schedules Nabilone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09104MIG. The term NABILONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 1, 2000, List 43). World Health Organization schedules nabilone in its Anatomical Therapeutic Chemical (ATC) Classification. NABILONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nabilone under HS 29329985 and SITC 51569. As of Q4 2014, NABILONE remains the US FDA Preferred Term for this commodity. Nabilone bears US NLM identifiers UMLS ID C1263104 and NCI Concept Code C1171. SMILES: O1C(C2C(CC(=O)CC2)C2C1CC(C(CCCCCC)(C)C)CC2O)(C)C.
Same parent
Under 51171800 · 49Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.